A Win For Bellerophon Therapeutics, Inc.
Tue, Mar 07, 2023 at 07:10 PM
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) jumped higher at $5, a gain of 42.5%. On Tue, Mar 07, 2023, BLPH:NASDAQ hit a New 2-Week High of $5. The stock got featured on our News Catalysts scanner on Thu, Feb 09, 2023 at 09:43 AM in the 'BIOTECH' category. From Tue, Feb 21, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 83.31%
- WW International, Inc. (WW:NASDAQ), 79.07%
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 51.91%
- ThredUp Inc. (TDUP:NASDAQ), 51.23%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 43.33%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 42.45%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Siyata Mobile Inc. (SYTA:NASDAQ), 32.65%
- Etao International Co. Ltd. (ETAO:NASDAQ), 30.74%
- Peak Bio Inc Com (PKBO:NASDAQ), 30.45%